Rumi Scientific is a spin-off from the labs of Ali Brivanlou and Eric Siggia at Rockefeller University, benefiting from more than a decade of cutting-edge basic research at the interface between human stem cell biology and physics. We are a research-driven company focused on the discovery of drugs and innovative treatments for human genetic diseases. We have created an exciting human organoid-based platform (see Haremaki et al., 2019, Nature Biotechnology for a recent example) that can be used for agnostic drug discovery and uniquely can be translated at the level of high-throughput screening. We have therefore unlocked the full potential of human organoids technology for the discovery of tomorrow’s therapeutics.